• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现蛋白质的高亲和力配体:基于核磁共振的构效关系研究。

Discovering high-affinity ligands for proteins: SAR by NMR.

作者信息

Shuker S B, Hajduk P J, Meadows R P, Fesik S W

机构信息

Pharmaceutical Discovery Division, Abbott Laboratories, Abbott Park, IL 60064, USA.

出版信息

Science. 1996 Nov 29;274(5292):1531-4. doi: 10.1126/science.274.5292.1531.

DOI:10.1126/science.274.5292.1531
PMID:8929414
Abstract

A nuclear magnetic resonance (NMR)-based method is described in which small organic molecules that bind to proximal subsites of a protein are identified, optimized, and linked together to produce high-affinity ligands. The approach is called "SAR by NMR" because structure-activity relationships (SAR) are obtained from NMR. With this technique, compounds with nanomolar affinities for the FK506 binding protein were rapidly discovered by tethering two ligands with micromolar affinities. The method reduces the amount of chemical synthesis and time required for the discovery of high-affinity ligands and appears particularly useful in target-directed drug research.

摘要

本文描述了一种基于核磁共振(NMR)的方法,该方法可识别、优化与蛋白质近端亚位点结合的小有机分子,并将它们连接在一起以产生高亲和力配体。这种方法被称为“基于核磁共振的构效关系研究”(SAR by NMR),因为构效关系(SAR)是通过核磁共振获得的。利用该技术,通过连接两个具有微摩尔亲和力的配体,迅速发现了对FK506结合蛋白具有纳摩尔亲和力的化合物。该方法减少了发现高亲和力配体所需的化学合成量和时间,在靶向药物研究中似乎特别有用。

相似文献

1
Discovering high-affinity ligands for proteins: SAR by NMR.发现蛋白质的高亲和力配体:基于核磁共振的构效关系研究。
Science. 1996 Nov 29;274(5292):1531-4. doi: 10.1126/science.274.5292.1531.
2
Nuclear magnetic resonance methods for studying protein-ligand complexes.
Methods Enzymol. 1994;239:717-39. doi: 10.1016/s0076-6879(94)39027-4.
3
Antascomicins A, B, C, D and E. Novel FKBP12 binding compounds from a Micromonospora strain.
J Antibiot (Tokyo). 1996 Mar;49(3):230-3. doi: 10.7164/antibiotics.49.230.
4
An automated method for dynamic ligand design.一种用于动态配体设计的自动化方法。
Proteins. 1995 Dec;23(4):472-90. doi: 10.1002/prot.340230403.
5
Dynamic NMR studies of ligand-receptor interactions: design and analysis of a rapidly exchanging complex of FKBP-12/FK506 with a 24 kDa calcineurin fragment.配体-受体相互作用的动态核磁共振研究:FKBP-12/FK506与24 kDa钙调神经磷酸酶片段快速交换复合物的设计与分析
Protein Sci. 1996 Sep;5(9):1917-21. doi: 10.1002/pro.5560050918.
6
Consensus preferred hydration sites in six FKBP12-drug complexes.六种FKBP12-药物复合物中一致认可的优先水合位点。
Proteins. 1995 Sep;23(1):1-11. doi: 10.1002/prot.340230103.
7
Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus).天然和突变型人重组FKBP12复合物与免疫抑制剂药物FK506(他克莫司)的结构比较。
Protein Sci. 1995 Nov;4(11):2261-8. doi: 10.1002/pro.5560041103.
8
Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases.肽基脯氨酰顺反异构酶FK506结合蛋白(FKBP)家族中的结构-功能关系。
Biochem J. 1996 Mar 1;314 ( Pt 2)(Pt 2):361-85.
9
Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR.通过异核三维和四维核磁共振确定溶液中FK506结合蛋白/子囊霉素复合物的三维结构。
Biochemistry. 1993 Jan 26;32(3):754-65. doi: 10.1021/bi00054a004.
10
15N NMR relaxation studies of the FK506 binding protein: dynamic effects of ligand binding and implications for calcineurin recognition.FK506结合蛋白的15N核磁共振弛豫研究:配体结合的动态效应及对钙调神经磷酸酶识别的影响
Biochemistry. 1994 Apr 12;33(14):4093-100. doi: 10.1021/bi00180a001.

引用本文的文献

1
Fragment-Based Development of Small Molecule Inhibitors Targeting Cholesterol Metabolism.基于片段的靶向胆固醇代谢小分子抑制剂的开发
J Med Chem. 2025 Jul 24;68(14):14416-14441. doi: 10.1021/acs.jmedchem.5c00478. Epub 2025 Jul 13.
2
NMR in the Age of Modern Biomedical Research and Drug Discovery.现代生物医学研究与药物发现时代的核磁共振技术
J Mol Biol. 2025 Jun 23:169302. doi: 10.1016/j.jmb.2025.169302.
3
From Concepts to Inhibitors: A Blueprint for Targeting Protein-Protein Interactions.从概念到抑制剂:靶向蛋白质-蛋白质相互作用的蓝图
Chem Rev. 2025 Jul 23;125(14):6819-6869. doi: 10.1021/acs.chemrev.5c00046. Epub 2025 Jun 24.
4
Target Engagement Assays in Early Drug Discovery.早期药物发现中的靶点结合分析
J Med Chem. 2025 Jun 26;68(12):12331-12368. doi: 10.1021/acs.jmedchem.4c03115. Epub 2025 Jun 4.
5
NMR-driven structure-based drug discovery by unveiling molecular interactions.通过揭示分子相互作用实现基于核磁共振驱动的结构药物发现。
Commun Chem. 2025 May 31;8(1):167. doi: 10.1038/s42004-025-01542-x.
6
Exploration of structure-activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment linking and active learning.基于形状的片段连接和主动学习对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)宏结构域进行构效关系探索
Sci Adv. 2025 May 30;11(22):eads7187. doi: 10.1126/sciadv.ads7187. Epub 2025 May 28.
7
Bibliometrics Analysis and Knowledge Mapping of Fragment-Based Drug Design Research: Trends from 2015 to 2024.基于片段的药物设计研究的文献计量学分析与知识图谱:2015年至2024年的趋势
Drug Des Devel Ther. 2025 May 22;19:4245-4262. doi: 10.2147/DDDT.S518489. eCollection 2025.
8
Where and how to house big data on small fragments.在小片段上存储大数据的位置及方式。
Nat Commun. 2025 May 5;16(1):4179. doi: 10.1038/s41467-025-59233-z.
9
CD36-mediated endocytosis of proteolysis-targeting chimeras.CD36介导的靶向蛋白水解嵌合体的内吞作用。
Cell. 2025 Jun 12;188(12):3219-3237.e18. doi: 10.1016/j.cell.2025.03.036. Epub 2025 Apr 17.
10
Beyond Isotopic Labeling: Expanding the Reach of Protein-Detect NMR in Lead Discovery.超越同位素标记:拓展蛋白质检测核磁共振在先导化合物发现中的应用范围
ACS Med Chem Lett. 2025 Mar 10;16(4):688-692. doi: 10.1021/acsmedchemlett.4c00540. eCollection 2025 Apr 10.